ArticleDermatology and therapy2022

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents.

Robert Sidbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.